Airway diseases
Interstitial lung diseases
Oral presentation
Advancements in paediatric infectious respiratory health
Methods :
Endoscopy and interventional pulmonology, Imaging, Cell and molecular biology, General respiratory patient care, Public health, Epidemiology
Chairs
S. Unger
Edinburgh (Edinburgh)
(United Kingdom)
15:45
Late Breaking Abstract - Recessively inherited deficiency of secreted WFDC2 (HE4) causes nasal polyposis and bronchiectasis
H. Omran(Münster, Germany)
COI
1
OA1984
15:50
A randomised controlled trial of hypertonic saline nose drops as a treatment in children with the common cold (ELVIS-Kids trial)
S. Cunningham(Edinburgh (Scotland), United Kingdom)
COI
2
OA1985
15:55
Creating Child-BEAR-Net’s international paediatric bronchiectasis registry: an ERS CRC initiative
L. Garriga Grimau(Barcelona, Spain)
COI
3
OA1986
16:00
Paediatric Bronchiectasis, a UK-wide cohort study
S. Unger(Edinburgh (Edinburgh), United Kingdom)
COI
4
OA1987
16:05
Characteristics of airway cilia motility and ultrastructure linked to heterotaxy but not associated with primary ciliary dyskinesia
L. Venditto(Verona, Italy)
COI
5
OA1988
16:10
Consensus definition of sinonasal and otologic exacerbation in patients with primary ciliary dyskinesia
M. Goutaki(Bern, Switzerland)
COI
6
OA1989
16:15
Medical clown intervention shortens length of hospitalization in children with community acquired pneumonia.
K. Yaacoby-Bianu(Haifa, Israel)
COI
7
OA1990
16:20
The impact of higher-valency pneumococcal conjugate vaccine use on pediatric parapneumonic pleural effusion/empyema in Belgium.
E. Lambert(Herent, Belgium)
COI
8
OA1991
16:25
Fever Duration Enhances Biomarker Sensitivity for Diagnosing Pediatric community acquired pneumonia
O. Goldberg(Rehovot, Israel)
COI
9
OA1992
16:30
Improvement of post-infectious bronchiolitis obliterans in children after methylprednisolone pulse therapy.
B. Dontje(Amsterdam, Netherlands)
COI
10
OA1993
16:35
Discussion and Q&A
11
OA1994
. . .
